Stakeholders

Representatives of patients, Parents and Survivors Organisations’, as well as individuals – members of the Childhood Cancer International Europe Region and the Unite2Cure Alliance.

Academic paediatric oncologists and haematologists – members of the European Consortium for Innovative Therapies for Children with Cancer (ITCC), members of the European Society of Paediatric Oncology (SIOPE), members of international cooperative paediatric oncology groups such as the Children’s Oncology Group (COG) and health professionals and basic and translational researchers with relevant expertise in the field of paediatric oncology and haematology.

Pharmaceutical Companies are represented by large, medium and small pharmaceutical companies. They may be from research and development (R&D) or regulatory affairs.

Regulatory Network Representatives from  – EMA, EMA Scientific committee, Food and Drug Administration and National competent authority staff, or any other regulatory agencies. Participation is exclusively in an advisory role in this external-led Platform, providing regulatory expert advice and guidance on future directions, when relevant. This includes explanations and suggestions. It is not contributing advice on individual product development.



For more information, please contact contact@accelerate-platform.org
You can tweet using #ACCELERATEplatform